Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis
Artur Y. Prilepskii, Nikita Serov, Daniil V. Kladko, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1056-1056
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs
B. V. P. Perera, Yuao Wu, Nam‐Trung Nguyen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100767-100767
Open Access | Times Cited: 26
New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Simin Farokhi, ZahraSadat Razavi, Maryamosadat Mavaei, et al.
Deleted Journal (2024) Vol. 6, Iss. 8
Open Access | Times Cited: 13
Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics
Boxuan Ma, Hong Xu, Yanan Wang, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 30, pp. 35410-35421
Closed Access | Times Cited: 52
Nanomaterial Shape Influence on Cell Behavior
Daniil V. Kladko, Aleksandra S. Falchevskaya, Nikita Serov, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5266-5266
Open Access | Times Cited: 50
Multifunctional pathology-mapping theranostic nanoplatforms for US/MR imaging and ultrasound therapy of atherosclerosis
Binyang Gao, Jinshun Xu, Jie Zhou, et al.
Nanoscale (2021) Vol. 13, Iss. 18, pp. 8623-8638
Closed Access | Times Cited: 41
Photodynamic Therapy for Atherosclerosis
Wiktoria Mytych, Dorota Bartusik‐Aebisher, Aleksandra Łoś, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1958-1958
Open Access | Times Cited: 6
Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging
Ibrahim Alradwan, Nojoud AL Fayez, Mohammad N. Alomary, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1037-1037
Open Access | Times Cited: 6
Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
Ming Zhang, Zhongjian Xie, Haijiao Long, et al.
Materials Today Bio (2022) Vol. 14, pp. 100236-100236
Open Access | Times Cited: 20
Design and Fabrication of Environmentally Responsive Nanoparticles for the Diagnosis and Treatment of Atherosclerosis
Jingyue Wang, Bingyang Lu, Ge Yin, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 3, pp. 1190-1206
Closed Access | Times Cited: 4
High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review
Juan Zhen, Xiangjun Li, Haitao Yu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation
Zhaojun Li, Mengjiao Zhang, Waicong Dai, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Molecular ZIP codes in targeted drug delivery
Erkki Ruoslahti
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 28
Open Access | Times Cited: 15
Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
Linsey J. F. Peters, Alexander Jans, Matthias Bartneck, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3185-3185
Open Access | Times Cited: 13
Dual-modality probe nanodrug delivery systems with ROS-sensitivity for atherosclerosis diagnosis and therapy
Meili Shen, Hui Jiang, Shaojing Li, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 5, pp. 1344-1354
Closed Access | Times Cited: 5
Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2
Luming Wang, Wenlan Zhang, Nuan Lyu, et al.
Chinese Journal of Integrative Medicine (2023) Vol. 30, Iss. 3, pp. 277-288
Closed Access | Times Cited: 5
ROS-Based Nanoparticles for Atherosclerosis Treatment
Xin Hu, Pengxuan Zhao, Yongping Lu, et al.
Materials (2021) Vol. 14, Iss. 22, pp. 6921-6921
Open Access | Times Cited: 11
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
Enrica Federti, Alessandro Mattè, Antonio Recchiuti, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e848-e848
Open Access | Times Cited: 4
Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis
Tianfeng Shi, Kunkun Liu, Yueyou Peng, et al.
Cardiovascular Drugs and Therapy (2023) Vol. 38, Iss. 5, pp. 977-997
Closed Access | Times Cited: 4
Nanomaterials for chronic inflammatory diseases: the current status and future prospects
Murtada A. Oshi, Adnan Haider, Muhammad Irfan Siddique, et al.
Applied Nanoscience (2021) Vol. 12, Iss. 11, pp. 3097-3110
Closed Access | Times Cited: 8
The Effect of pH and Buffer on Oligonucleotide Affinity for Iron Oxide Nanoparticles
Ekaterina Bobrikova, Alexey S. Chubarov, Elena Dmitrienko
Magnetochemistry (2021) Vol. 7, Iss. 9, pp. 128-128
Open Access | Times Cited: 8
Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual‐Track Reverse Cholesterol Transport Strategy
Zhezhe Chen, Qiongjun Zhu, Duanbin Li, et al.
Small (2023) Vol. 20, Iss. 7
Closed Access | Times Cited: 3
Toxicity assessment of the selenium nanoparticles in vitro ‎
Sofya Olegovna Budagova, Gregory Vadimovich Nadvodnyk, Polina Alexandrovna Belskaia, et al.
Journal Of Advanced Pharmacy Education And Research (2023) Vol. 13, Iss. 3, pp. 39-45
Open Access | Times Cited: 2
Cardiovascular Tissue Engineering Models for Atherosclerosis Treatment Development
Linnea Tscheuschner, Abraham R. Tzafriri
Bioengineering (2023) Vol. 10, Iss. 12, pp. 1373-1373
Open Access | Times Cited: 2
Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles
Kristen Hong, Minzhi Yu, Julia Crowther, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1570-1570
Open Access | Times Cited: 3
Comparison of Cell-based and Nanoparticle-based Therapeutics in Treating Atherosclerosis
Wen Xi Goh, Yih-Yih Kok, Chiew-Yen Wong
Current Pharmaceutical Design (2023) Vol. 29, Iss. 35, pp. 2827-2840
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top